Magnera director granted 12,998 RSUs

Hall Mary Dean reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/10/2026 - 11:51 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hall Mary Dean reported acquisition or exercise transactions in this Form 4 filing.

Magnera Corp director Mary Dean Hall received a grant of 12,998 Restricted Stock Units. These RSUs were awarded at no cash cost and will vest in full, with all restrictions lapsing, one year from the grant date. According to the disclosure, the RSUs have no value until all restrictions lapse on the final vesting date.

Insider Trade Summary

Grant/Award: 12,998 shares

Grant/Award 1 txn

Insider Hall Mary Dean

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	12,998	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 12,998 contracts (Direct)

Footnotes (2)

1. F1. Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date.
2. F2. This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Magnera Corp (MAGN) report for Mary Dean Hall?

Magnera Corp director Mary Dean Hall received a grant of 12,998 Restricted Stock Units. These units were awarded at no cash cost and represent equity-based compensation, subject to vesting conditions before they have realizable value for the director.

How many Restricted Stock Units did Magnera Corp (MAGN) grant to its director?

Magnera Corp granted director Mary Dean Hall 12,998 Restricted Stock Units. This entire amount is reflected as her direct holdings after the transaction, contingent on the vesting schedule and related restrictions described in the accompanying disclosure footnotes.

When do Mary Dean Hall’s Magnera Corp (MAGN) RSUs vest?

The 2026 director grant of Restricted Stock Units for Mary Dean Hall vests in full one year from the grant date. All associated restrictions lapse at that time, turning the RSUs into value-bearing equity once the vesting condition has been satisfied.

Do the Magnera Corp (MAGN) RSUs granted to Mary Dean Hall have immediate value?

The Restricted Stock Units currently have no value until all restrictions lapse on the final vesting date. Only after the one-year vesting period is complete do they become fully vested equity that can have realizable economic value to the director.

Is Mary Dean Hall’s Magnera Corp (MAGN) RSU grant a cash purchase of shares?

No, the grant is an equity award of Restricted Stock Units at a stated price of zero per unit. It represents stock-based compensation, not an open-market cash purchase of Magnera Corp shares by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hall Mary Dean

(Last) (First) (Middle)

9335 HARRIS CORNERS PKWY

SUITE 300

(Street)

CHARLOTTE NC 28269

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Magnera Corp [ MAGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/09/2026		A		12,998		03/09/2027(2)	03/09/2027	Common Stock, Par Value $.01	12,998	$0	12,998	D

Explanation of Responses:

1. Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date.

2. This 2026 Director grant vests in full and all restrictions lapse one year from the Grant Date.

	/s/ Laura A. Jones, attorney-in-fact for Mary Hall	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.